ADMA Biologics (ADMA) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

ADMA Biologics Revenue Highlights


Latest Revenue (Y)

$258.21M

Latest Revenue (Q)

$119.84M

Main Segment (Y)

ADMA BioManufacturing Segment

Main Geography (Y)

United States

ADMA Biologics Revenue by Period


ADMA Biologics Revenue by Year

DateRevenueChange
2023-12-31$258.21M67.59%
2022-12-31$154.08M90.36%
2021-12-31$80.94M91.72%
2020-12-31$42.22M43.85%
2019-12-31$29.35M72.79%
2018-12-31$16.99M-25.37%
2017-12-31$22.76M113.49%
2016-12-31$10.66M48.53%
2015-12-31$7.18M21.34%
2014-12-31$5.92M92.84%
2013-12-31$3.07M174.35%
2012-12-31$1.12M100.00%
2011-06-30-100.00%
2010-06-30-100.00%
2009-06-30-100.00%
2008-06-30-100.00%
2007-06-30--

ADMA Biologics generated $258.21M in revenue during NA 2023, up 67.59% compared to the previous quarter, and up 1520.23% compared to the same period a year ago.

ADMA Biologics Revenue by Quarter

DateRevenueChange
2024-09-30$119.84M11.80%
2024-06-30$107.19M30.92%
2024-03-31$81.88M10.79%
2023-12-31$73.90M9.85%
2023-09-30$67.27M11.89%
2023-06-30$60.12M5.64%
2023-03-31$56.91M13.87%
2022-12-31$49.98M21.64%
2022-09-30$41.09M21.19%
2022-06-30$33.91M16.50%
2022-03-31$29.10M10.31%
2021-12-31$26.38M27.57%
2021-09-30$20.68M15.98%
2021-06-30$17.83M11.10%
2021-03-31$16.05M14.99%
2020-12-31$13.96M35.81%
2020-09-30$10.28M31.96%
2020-06-30$7.79M-23.65%
2020-03-31$10.20M-15.26%
2019-12-31$12.04M66.66%
2019-09-30$7.22M10.08%
2019-06-30$6.56M85.94%
2019-03-31$3.53M-13.01%
2018-12-31$4.06M-4.11%
2018-09-30$4.23M-9.15%
2018-06-30$4.66M15.20%
2018-03-31$4.04M-66.32%
2017-12-31$12.00M153.79%
2017-09-30$4.73M39.12%
2017-06-30$3.40M29.31%
2017-03-31$2.63M-21.00%
2016-12-31$3.33M13.26%
2016-09-30$2.94M29.32%
2016-06-30$2.27M6.96%
2016-03-31$2.12M-15.46%
2015-12-31$2.51M35.62%
2015-09-30$1.85M41.41%
2015-06-30$1.31M-12.85%
2015-03-31$1.50M0.97%
2014-12-31$1.49M8.99%
2014-09-30$1.37M-8.96%
2014-06-30$1.50M-3.86%
2014-03-31$1.56M268.03%
2013-12-31$424.03K-61.71%
2013-09-30$1.11M48.98%
2013-06-30$743.27K-6.26%
2013-03-31$792.93K51.53%
2012-12-31$523.28K45.22%
2012-09-30$360.34K56.60%
2012-06-30$230.10K5129.45%
2012-03-31$4.40K100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-09-30--

ADMA Biologics generated $119.84M in revenue during Q3 2024, up 11.80% compared to the previous quarter, and up 199.32% compared to the same period a year ago.

ADMA Biologics Revenue Breakdown


ADMA Biologics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 19
Plasma Collection Centers Segment$8.12M---
ADMA BioManufacturing Segment$161.16M---
Product Revenue-$153.94M$80.80M-
License Revenue-$142.83K$142.83K-
Corporate---$142.83K
ADMA BioManufacturing---$22.18M
Plasma Collection Centers---$7.03M

ADMA Biologics's latest annual revenue breakdown by segment (product or service), as of Dec 23: ADMA BioManufacturing Segment (95.21%), and Plasma Collection Centers Segment (4.79%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 20Dec 19Sep 19Jun 19Mar 19
ADMA BioManufacturing Segment$113.09M$80.11M$51.82M$59.76M$49.58M------------
Plasma Collection Centers Segment$7.45M$1.78M$488.76K$326.35K$7.30M------------
Corporate Segment$36.00K$36.00K$35.71K$35.71K-------------
Product Revenue-----$49.95M$41.05M$33.87M$29.07M$26.35M$20.64M$17.79M-----
License Revenue-----$35.71K$35.71K$35.71K$35.71K$35.71K$35.71K$35.71K-----
ADMA BioManufacturing------------$7.74M$10.96M$5.87M$4.00M$1.34M
Plasma Collection Centers------------$2.42M$1.04M$1.32M$2.52M$2.15M
Corporate------------$35.71K$35.71K$35.71K$35.71K$35.71K

ADMA Biologics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: ADMA BioManufacturing Segment (93.79%), Plasma Collection Centers Segment (6.18%), and Corporate Segment (0.03%).

ADMA Biologics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22
United States$146.43M

ADMA Biologics's latest annual revenue breakdown by geography, as of Dec 22: United States (100.00%).

Quarterly Revenue by Country

CountrySep 24Mar 24Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
United States$114.75M$77.99M$56.61M$52.69M$49.98M$37.85M$31.27M$27.32M
International$5.09M$3.88M------

ADMA Biologics's latest quarterly revenue breakdown by geography, as of Sep 24: United States (95.75%), and International (4.25%).

ADMA Biologics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BCRXBioCryst Pharmaceuticals$331.41M$117.08M
ADMAADMA Biologics$258.21M$119.84M
AKBAAkebia Therapeutics$194.62M$35.59M
MCRBSeres Therapeutics$126.33M-
RCUSArcus Biosciences$117.00M$48.00M
ACLXArcellx$110.32M$26.03M
CDTXCidara Therapeutics$63.91M-
FATEFate Therapeutics$63.53M$6.77M
CRBUCaribou Biosciences$34.48M$3.46M
STOKStoke Therapeutics$8.78M$4.89M
ATRAAtara Biotherapeutics$8.57M$40.19M
TNXPTonix Pharmaceuticals$7.77M$2.21M
VXRTVaxart$7.38M$6.40M
PLRXPliant Therapeutics$1.58M-
TFFPTFF Pharmaceuticals$733.87K$650.22K
ANEBAnebulo Pharmaceuticals--
XFORX4 Pharmaceuticals-$563.00K
ANTXAN2 Therapeutics--
MDGLMadrigal Pharmaceuticals-$62.17M
ETNB89bio--
SANASana Bio--
INMBINmune Bio$-155.00K-

ADMA Revenue FAQ


What is ADMA Biologics’s yearly revenue?

ADMA Biologics's yearly revenue for 2023 was $258.22M, representing an increase of 67.59% compared to 2022. The company's yearly revenue for 2022 was $154.08M, representing an increase of 90.36% compared to 2021. ADMA's yearly revenue for 2021 was $80.94M, representing an increase of 91.72% compared to 2020.

What is ADMA Biologics’s quarterly revenue?

ADMA Biologics's quarterly revenue for Q3 2024 was $119.84M, a 11.80% increase from the previous quarter (Q2 2024), and a 78.13% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $107.19M, a 30.92% increase from the previous quarter (Q1 2024), and a 78.29% increase year-over-year (Q2 2023). ADMA's quarterly revenue for Q1 2024 was $81.88M, a 10.79% increase from the previous quarter (Q4 2023), and a 43.86% increase year-over-year (Q1 2023).

What is ADMA Biologics’s revenue growth rate?

ADMA Biologics's revenue growth rate for the last 3 years (2021-2023) was 219.01%, and for the last 5 years (2019-2023) was 779.81%.

What are ADMA Biologics’s revenue streams?

ADMA Biologics's revenue streams in c 23 are Plasma Collection Centers Segment, and ADMA BioManufacturing Segment. Plasma Collection Centers Segment generated $8.12M in revenue, accounting 4.79% of the company's total revenue ADMA BioManufacturing Segment generated $161.16M in revenue, accounting 95.21% of the company's total revenue

What is ADMA Biologics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of ADMA Biologics was ADMA BioManufacturing Segment. This segment made a revenue of $161.16M, representing 95.21% of the company's total revenue.